Recursion Pharmaceuticals, Inc.
RXRX
$5.68
-$0.27-4.54%
NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 500.45M | 594.35M | 427.65M | 474.34M | 296.33M |
| Total Receivables | 46.12M | 49.17M | 2.26M | 2.53M | 2.60M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.47M | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 35.10M | 70.75M | 44.27M | 45.51M | 44.69M |
| Total Current Assets | 584.15M | 714.27M | 474.17M | 522.38M | 343.62M |
|
|
|||||
| Total Current Assets | 584.15M | 714.27M | 474.17M | 522.38M | 343.62M |
| Net Property, Plant & Equipment | 204.78M | 233.21M | 159.19M | 156.28M | 122.22M |
| Long-term Investments | 158.11M | 148.87M | 52.06M | 52.06M | 52.06M |
| Goodwill | 158.11M | 148.87M | 52.06M | 52.06M | 52.06M |
| Total Other Intangibles | 335.79M | 335.86M | 34.09M | 38.21M | 33.08M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 18.01M | 16.39M | 6.99M | 6.94M | 6.88M |
| Total Assets | 1.31B | 1.45B | 726.50M | 775.86M | 557.85M |
|
|
|||||
| Total Accounts Payable | 25.09M | 21.61M | 2.26M | 3.76M | 5.12M |
| Total Accrued Expenses | 55.18M | 80.28M | 38.71M | 31.48M | 24.89M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 20.44M | 22.22M | 16.45M | 16.72M | 6.12M |
| Total Finance Division Other Current Liabilities | 41.28M | 63.36M | 51.47M | 34.12M | 37.80M |
| Total Other Current Liabilities | 41.28M | 63.36M | 51.47M | 34.12M | 37.80M |
| Total Current Liabilities | 141.98M | 187.47M | 108.89M | 86.08M | 73.92M |
|
|
|||||
| Total Current Liabilities | 141.98M | 187.47M | 108.89M | 86.08M | 73.92M |
| Long-Term Debt | 16.45M | 684.00K | 1.02M | -- | 1.07M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 56.02M | 85.59M | 73.16M | 73.16M | 43.79M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 156.84M | 140.07M | 18.88M | 32.17M | 37.92M |
| Total Liabilities | 371.29M | 413.82M | 201.94M | 191.41M | 156.70M |
|
|
|||||
| Common Stock & APIC | 2.55B | 2.47B | 1.78B | 1.74B | 1.46B |
| Retained Earnings | -1.63B | -1.43B | -1.25B | -1.16B | -1.06B |
| Treasury Stock & Other | 14.15M | -7.64M | -- | -- | -- |
| Total Common Equity | 933.95M | 1.03B | 524.56M | 584.45M | 401.15M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 933.95M | 1.03B | 524.56M | 584.45M | 401.15M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 933.95M | 1.03B | 524.56M | 584.45M | 401.15M |
|
|
|||||